| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.05 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.081 | 0.05 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.05 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.05 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |